UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Short-course antibiotic treatment for Gram-negative bloodstream infection in neutropenic cancer patients: Less is more

Transplant infectious disease, 2023-10, Vol.25 (5), p.e14106-e14106

2023

Volltextzugriff (PDF)

Understanding and Managing Sepsis in Patients With Cancer in the Era of Antimicrobial Resistance

Frontiers in medicine, 2021-03, Vol.8, p.636547-636547

2021

Volltextzugriff (PDF)

The direct and indirect effects of COVID‐19 pandemic in a real‐life hematological setting

Cancer reports, 2021-08, Vol.4 (4), p.e1358-n/a

2021

Volltextzugriff (PDF)

Simultaneous CMV and Listeria infection following alemtuzumab treatment for multiple sclerosis

Neurology, 2019-02, Vol.92 (6), p.296-298

2019

Volltextzugriff (PDF)

Isavuconazole prophylaxis against invasive fungal infections in allogeneic stem cell transplantation: A single-center experience

Hematology, Transfusion and Cell Therapy, 2022-07, Vol.44 (3), p.440-443

2022

Volltextzugriff (PDF)

Oncostatin M is expressed in atherosclerotic lesions: A role for Oncostatin M in the pathogenesis of atherosclerosis

Atherosclerosis, 2011-06, Vol.216 (2), p.292-298

2011

Volltextzugriff (PDF)

Update on the management of febrile neutropenia in hematologic patients

Revista española de quimioterapia, 2019-09, Vol.32 Suppl 2 (Suppl 2), p.55-58

2019

Volltextzugriff (PDF)

Inappropriate Empirical Antibiotic Treatment in High-risk Neutropenic Patients With Bacteremia in the Era of Multidrug Resistance

Clinical infectious diseases, 2020-03, Vol.70 (6), p.1068-1074

2020

Volltextzugriff (PDF)

Impact of Empirical Antibiotic Regimens on Mortality in Neutropenic Patients with Bloodstream Infection Presenting with Septic Shock

Antimicrobial agents and chemotherapy, 2022-02, Vol.66 (2), p.e0174421-e0174421

2022

Volltextzugriff (PDF)

Incidence, Risk Factors and Clinical Impact of Sars-Cov-2 Prolonged Viral Shedding in Patients Diagnosed with Hematologic Malignancies

Blood, 2023-11, Vol.142 (Supplement 1), p.3927-3927

2023

Volltextzugriff (PDF)

Handling the COVID-19 pandemic in the oncological setting

The Lancet. Haematology, 2020-05, Vol.7 (5), p.e365-e366

2020

Volltextzugriff (PDF)

Phase I Clinical Trial to Evaluate the Safety of Baricitinib to Prevent Respiratory Insufficiency Progression in Oncohematological Patients Affected with COVID-19 - BARCOVID19 Study

Blood, 2022-11, Vol.140 (Supplement 1), p.10750-10751

2022

Volltextzugriff (PDF)

Adenovirus-induced hemorrhagic cystitis after CD19-targeted chimeric antigen receptor T-cell therapy in a patient with large B-cell lymphoma

Immunotherapy, 2023-11, Vol.15 (16), p.1369-1374

2023

Volltextzugriff (PDF)

Extended Infusion of Broad-spectrum β-Lactams in High-risk Febrile Neutropenic Patients

Clinical infectious diseases, 2019-02, Vol.68 (5), p.890-890

2019

Volltextzugriff (PDF)

Impact of Cytomegalovirus Replication in Patients with Aggressive B Cell Lymphoma Treated with Chimeric Antigen Receptor T Cell Therapy

Transplantation and cellular therapy, 2022-12, Vol.28 (12), p.851.e1-851.e8

2022

Volltextzugriff (PDF)

Opposing roles of STAT-1 and STAT-3 in regulating vascular endothelial growth factor expression in vascular smooth muscle cells

Biochemical and biophysical research communications, 2012-11, Vol.428 (1), p.179-184

2012

Volltextzugriff (PDF)

A Randomized, Double-Blind, Placebo-Controlled Trial (TAURCAT Study) of Citrate Lock Solution for Prevention of Endoluminal Central Venous Catheter Infection in Neutropenic Hematological Patients

Antimicrobial agents and chemotherapy, 2020-01, Vol.64 (2)

2020

Volltextzugriff (PDF)

Modulation of vascular smooth muscle cell phenotype by STAT-1 and STAT-3

Atherosclerosis, 2014-05, Vol.234 (1), p.169-175

2014

Volltextzugriff (PDF)

Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study)

Microbiology spectrum, 2022-06, Vol.10 (3), p.e0229221-e0229221

2022

Volltextzugriff (PDF)

Isavuconazole prophylaxis against invasive fungal infections in allogeneic stem cell transplantation: A single-center experience

Hematology, transfusion and cell therapy, 2022, Vol.44 (3), p.440-443

2022

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(21)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Short-course antibiotic treatment for Gram-negative bloodstream infection in neutropenic cancer patients: Less is more

Understanding and Managing Sepsis in Patients With Cancer in the Era of Antimicrobial Resistance

The direct and indirect effects of COVID‐19 pandemic in a real‐life hematological setting

Simultaneous CMV and Listeria infection following alemtuzumab treatment for multiple sclerosis

Isavuconazole prophylaxis against invasive fungal infections in allogeneic stem cell transplantation: A single-center experience

Oncostatin M is expressed in atherosclerotic lesions: A role for Oncostatin M in the pathogenesis of atherosclerosis

Update on the management of febrile neutropenia in hematologic patients

Inappropriate Empirical Antibiotic Treatment in High-risk Neutropenic Patients With Bacteremia in the Era of Multidrug Resistance

Impact of Empirical Antibiotic Regimens on Mortality in Neutropenic Patients with Bloodstream Infection Presenting with Septic Shock

Incidence, Risk Factors and Clinical Impact of Sars-Cov-2 Prolonged Viral Shedding in Patients Diagnosed with Hematologic Malignancies

Impact of Antibacterial Prophylaxis on Morbidity-Mortality of Patients with Myeloid Neoplasms Treated with Non-Intensive Venetoclax Combinations

Handling the COVID-19 pandemic in the oncological setting

Phase I Clinical Trial to Evaluate the Safety of Baricitinib to Prevent Respiratory Insufficiency Progression in Oncohematological Patients Affected with COVID-19 - BARCOVID19 Study

Adenovirus-induced hemorrhagic cystitis after CD19-targeted chimeric antigen receptor T-cell therapy in a patient with large B-cell lymphoma

Extended Infusion of Broad-spectrum β-Lactams in High-risk Febrile Neutropenic Patients

Impact of Cytomegalovirus Replication in Patients with Aggressive B Cell Lymphoma Treated with Chimeric Antigen Receptor T Cell Therapy

Opposing roles of STAT-1 and STAT-3 in regulating vascular endothelial growth factor expression in vascular smooth muscle cells

A Randomized, Double-Blind, Placebo-Controlled Trial (TAURCAT Study) of Citrate Lock Solution for Prevention of Endoluminal Central Venous Catheter Infection in Neutropenic Hematological Patients

Modulation of vascular smooth muscle cell phenotype by STAT-1 and STAT-3

Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study)

COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain

Isavuconazole prophylaxis against invasive fungal infections in allogeneic stem cell transplantation: A single-center experience

Suchergebnisse filtern